Mylan
Latest Stories
6_262018_allyson-schwartz8201.jpg
Allyson Schwartz (Photo by Mylan Cannon/APCO Worldwide)
earns_mylan_15992.jpg
This Oct. 10, 2013, file photo, shows an EpiPen epinephrine auto-injector, a Mylan product, in Hendersonville, Texas. Mylan reports earnings Wednesday, Aug. 9, 2017. (AP Photo/Mark Zaleski, File)
california_legislature_things_to_know_72085.jpg
FILE - In this July 8, 2016, file photo, a pharmacist holds a package of EpiPens epinephrine auto-injectors, a Mylan product that has seen its cost skyrocket, in Sacramento, Calif. With the state budget passed, lawmakers are considering a variety of measures they hope would constrain the growth of drug prices. (AP Photo/Rich Pedroncelli, File)
mylan-executive_pay_protest_48026.jpg
FILE - This Oct. 10, 2013, file photo, shows an EpiPen epinephrine auto-injector, a Mylan product, in Hendersonville, Texas. Some big pension funds are urging shareholders of EpiPen maker Mylan to reject several company directors and the compensation it gives top executives, including the nearly $100 million Chairman and former CEO Robert Coury received last year. The pension funds say that the compensation came during backlash over prices the drugmaker charged for its EpiPen emergency allergy treatment. They also note that the company agreed to make “extraordinary and egregious” payments last year and over the next five years to Coury.(AP Photo/Mark Zaleski, File)
EpiPen.jpg
Mylan had raised the price from $100 for an EpiPen twin pack in 2009 to more than $600 in 2016. (Associated Press)
california_new_laws_20805.jpg
In this July 8, 2016, file photo, a pharmacist holds a package of EpiPens epinephrine auto-injector, a Mylan product, in Sacramento, Calif. Businesses will be allowed to stock EpiPens used to treat people having life-threatening allergic reactions under AB1386, which allows pharmacies to dispense the devices to colleges, private businesses and other venues that have a plan in place for using them. (AP Photo/Rich Pedroncelli, File)
epipen-mylan_overcharges.jpeg
FILE - In this Wednesday, Sept. 21, 2016, file photo, Mylan CEO Heather Bresch holds up EpiPens while testifying on Capitol Hill in Washington, before the House Oversight Committee hearing on EpiPen price increases. Now the federal government, responding to Congressional inquiries, says EpiPen's maker has been overcharging Medicaid for years because the emergency shot is classified incorrectly as a generic medicine, so Mylan has been paying the government much-lower rebates off the price than it should. (AP Photo/Pablo Martinez Monsivais, File)
drug_costs_enablers.jpeg
FILE - In this Sept. 21, 2016 file photo, Mylan CEO Heather Bresch testifies on Capitol Hill in Washington. Lawmakers are venting outrage these days over high prescription drug costs, but if Congress is looking for culprits, it may want to look in the mirror. Republican and Democratic-controlled Congresses, and presidents of both parties, may have set the stage for the startling prices that now have consumers on edge. (AP Photo/Pablo Martinez Monsivais, File)
Congress EpiPen.JPEG-5485f.jpg
In this Sept. 21, 2016 file photo, EpiPens brought by Mylan CEO Heather Bresch are seen on Capitol Hill in Washington as she testified before the House Oversight Committee hearing on EpiPen price increases. (AP Photo/Pablo Martinez Monsivais, File)
aptopix_congress_epipen.jpeg
Mylan CEO Heather Bresch testifies on Capitol Hill in Washington, Wednesday, Sept. 21, 2016, before the House Oversight Committee hearing on EpiPen price increases. Bresch defended the cost for life-saving EpiPens, signaling the company has no plans to lower prices despite a public outcry and questions from skeptical lawmakers. (AP Photo/Pablo Martinez Monsivais)
Congress EpiPen.JPEG-4ff75.jpg
FILE - In this July 8, 2016, file photo, a pharmacist holds a package of EpiPens epinephrine auto-injector, a Mylan product, in Sacramento, Calif. Mylan CEO Heather Bresch is defending the cost for life-saving EpiPens and is offering no suggestion that there are plans to lower prices. Bresch’s prepared testimony was released by the House Oversight and Government Reform Committee ahead of her Sept. 21 appearance before the panel. (AP Photo/Rich Pedroncelli, File)
Drug Price Transparency.JPEG-80d1f.jpg
In this July 8, 2016, file photo, a pharmacist holds a package of EpiPens epinephrine auto-injector, a Mylan product, in Sacramento, Calif. Mylan said it will make available a generic version of its EpiPen, as criticism mounts over the price of its injectable medicine. (AP Photo/Rich Pedroncelli, File)
Drug Price Transparency.JPEG-826d3.jpg
In this Friday, July 8, 2016 photo, a pharmacist holds a package of EpiPens, an epinephrine autoinjector for the treatment of allergic reactions, in Sacramento, Calif. Price hikes for the emergency medicine have made its maker, Mylan, the latest target for patients and politicians infuriated by soaring drug prices. (AP Photo/Rich Pedroncelli)
